These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32972350)

  • 1. Chemical IN04 Inhibits the Kinase Domain not the ROC Domain of LRRK1: Results from Homology Modeling and Molecular Docking.
    Chen Z; Xing W; Fan L
    Med Chem; 2021; 17(10):1140-1150. PubMed ID: 32972350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small molecular inhibitor of LRRK1 identified by homology modeling and virtual screening suppresses osteoclast function, but not osteoclast differentiation,
    Si M; Zeng C; Goodluck H; Shen S; Mohan S; Xing W
    Aging (Albany NY); 2019 May; 11(10):3250-3261. PubMed ID: 31113907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain.
    Malik AU; Karapetsas A; Nirujogi RS; Chatterjee D; Phung TK; Wightman M; Gourlay R; Morrice N; Mathea S; Knapp S; Alessi DR
    Biochem J; 2022 Sep; 479(18):1941-1965. PubMed ID: 36040231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms.
    Malik AU; Karapetsas A; Nirujogi RS; Mathea S; Chatterjee D; Pal P; Lis P; Taylor M; Purlyte E; Gourlay R; Dorward M; Weidlich S; Toth R; Polinski NK; Knapp S; Tonelli F; Alessi DR
    Biochem J; 2021 Feb; 478(3):553-578. PubMed ID: 33459343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine-rich repeat kinase-1 regulates osteoclast function by modulating RAC1/Cdc42 Small GTPase phosphorylation and activation.
    Zeng C; Goodluck H; Qin X; Liu B; Mohan S; Xing W
    Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E772-E780. PubMed ID: 27600824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain.
    Korr D; Toschi L; Donner P; Pohlenz HD; Kreft B; Weiss B
    Cell Signal; 2006 Jun; 18(6):910-20. PubMed ID: 16243488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions?
    Civiero L; Bubacco L
    Biochem Soc Trans; 2012 Oct; 40(5):1095-101. PubMed ID: 22988872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Parkinson disease gene LRRK2: evolutionary and structural insights.
    Marín I
    Mol Biol Evol; 2006 Dec; 23(12):2423-33. PubMed ID: 16966681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis.
    Xing W; Liu J; Cheng S; Vogel P; Mohan S; Brommage R
    J Bone Miner Res; 2013 Sep; 28(9):1962-74. PubMed ID: 23526378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers.
    Civiero L; Vancraenenbroeck R; Belluzzi E; Beilina A; Lobbestael E; Reyniers L; Gao F; Micetic I; De Maeyer M; Bubacco L; Baekelandt V; Cookson MR; Greggio E; Taymans JM
    PLoS One; 2012; 7(8):e43472. PubMed ID: 22952686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and regulation of full-length human leucine-rich repeat kinase 1.
    Metcalfe RD; Martinez Fiesco JA; Bonet-Ponce L; Kluss JH; Cookson MR; Zhang P
    Nat Commun; 2023 Aug; 14(1):4797. PubMed ID: 37558661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways.
    Reyniers L; Del Giudice MG; Civiero L; Belluzzi E; Lobbestael E; Beilina A; Arrigoni G; Derua R; Waelkens E; Li Y; Crosio C; Iaccarino C; Cookson MR; Baekelandt V; Greggio E; Taymans JM
    J Neurochem; 2014 Oct; 131(2):239-50. PubMed ID: 24947832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease.
    Blauwendraat C; Reed X; Kia DA; Gan-Or Z; Lesage S; Pihlstrøm L; Guerreiro R; Gibbs JR; Sabir M; Ahmed S; Ding J; Alcalay RN; Hassin-Baer S; Pittman AM; Brooks J; Edsall C; Hernandez DG; Chung SJ; Goldwurm S; Toft M; Schulte C; Bras J; Wood NW; Brice A; Morris HR; Scholz SW; Nalls MA; Singleton AB; Cookson MR;
    JAMA Neurol; 2018 Nov; 75(11):1416-1422. PubMed ID: 30039155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease.
    Taylor JP; Hulihan MM; Kachergus JM; Melrose HL; Lincoln SJ; Hinkle KM; Stone JT; Ross OA; Hauser R; Aasly J; Gasser T; Payami H; Wszolek ZK; Farrer MJ
    Neurogenetics; 2007 Apr; 8(2):95-102. PubMed ID: 17225181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase.
    Deng J; Lewis PA; Greggio E; Sluch E; Beilina A; Cookson MR
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1499-504. PubMed ID: 18230735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of LRRK1 and mechanisms of autoinhibition and activation.
    Reimer JM; Dickey AM; Lin YX; Abrisch RG; Mathea S; Chatterjee D; Fay EJ; Knapp S; Daugherty MD; Reck-Peterson SL; Leschziner AE
    Nat Struct Mol Biol; 2023 Nov; 30(11):1735-1745. PubMed ID: 37857821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1.
    Greggio E; Lewis PA; van der Brug MP; Ahmad R; Kaganovich A; Ding J; Beilina A; Baker AK; Cookson MR
    J Neurochem; 2007 Jul; 102(1):93-102. PubMed ID: 17394548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease.
    Westerlund M; Belin AC; Anvret A; Bickford P; Olson L; Galter D
    Neuroscience; 2008 Mar; 152(2):429-36. PubMed ID: 18272292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Roc-COR tandem domain of leucine-rich repeat kinase 2 forms dimers and exhibits conventional Ras-like GTPase properties.
    Mills RD; Liang LY; Lio DS; Mok YF; Mulhern TD; Cao G; Griffin M; Kenche VB; Culvenor JG; Cheng HC
    J Neurochem; 2018 Nov; 147(3):409-428. PubMed ID: 30091236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.
    Vancraenenbroeck R; Lobbestael E; Weeks SD; Strelkov SV; Baekelandt V; Taymans JM; De Maeyer M
    Biochim Biophys Acta; 2012 Mar; 1824(3):450-60. PubMed ID: 22251894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.